Covid-19 herd immunity is not going to happen, so what next?

03 August 2021 - 14:04 By Shabir A Madhi
subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now
Wits University's Prof Shabir Madhi says we are going to have to learn to live with the coronavirus. File photo.
Wits University's Prof Shabir Madhi says we are going to have to learn to live with the coronavirus. File photo.
Image: SUNDAY TIMES/ALAISTER RUSSELL

Any notion that Covid-19 was going to last for a few months was very much misplaced in 2020. After it was recognised the SARS-CoV-2 virus was largely spread through the airborne route, all indications were it would cause repeat bouts of waves. This is what happened during the flu epidemic of 1918.

In addition, very few scientists predicted we would see the type of mutations that occurred over such a short period. This has resulted in the virus becoming both more transmissible and more able to evade immune responses.

The evolution of the virus has been so rapid that the Delta variant, which is currently dominating the world, is at least twice as transmissible as the ancestral virus that was circulating.

What this means is that herd immunity is no longer a discussion the world should be having. We should start to avoid using that term in the context of SARS-CoV-2 because it’s not going to materialise — or is unlikely to materialise — during our lifetimes.

When politicians and others speak about herd immunity, unfortunately they are under the misconception that the current tools we’ve got are adequate to eliminate the virus. It’s not what we have at hand right now.

Instead we should be talking about how to live with the virus. The tremendous success that has materialised with Covid-19 vaccines allows us to do this without getting into the herd immunity threshold.

Peddling the concept of herd immunity creates a misconception that we are going to get to a stage where this virus is going to be eliminated. That’s unlikely to happen. It will continue circulating.

There are a number of dangers in continuing to make people believe it is possible.

First, it could dent confidence in vaccines. Even if SA gets to its target of 67% of the population being vaccinated — as set out by the Department of Health — there will still be outbreaks of Covid-19. The result will be that people begin to doubt the benefits of being vaccinated. Also, for the dominant Delta variant, immunity against infection (not only Covid-19 illness) would need to be closer to 84% for the herd immunity threshold to be reached.

Second, failing to face up to the reality that herd immunity can’t be achieved will mean that countries like SA will continue to believe ongoing restrictions will get them there. That will compromise the lives of people on multiple fronts — including education and livelihoods.

What is herd immunity?

Herd immunity is when someone infected by the virus won’t, on average, infect another person. You reach a state where the immunity in the population against infection by the virus is such that there are too few people in the environment for sustained onward transmission to take place to others.

This is because they’ve developed immunity against being infected, or at least have developed immunity to the extent where even if they were infected, they would be able to clear the virus very quickly and wouldn’t be able to transmit it to other people.

Herd immunity essentially means you have brought about an absolute interruption in the chain of transmission of the virus in the population in the absence of other interventions that could also interrupt virus transmission, such as wearing of face masks.

But some changes have forced a shift in our thinking about herd immunity. It’s now viewed much more as an aspiration rather than a goal.

What’s changed

First, the evolution of the virus and the mutations that have occurred.

One set of mutations made the virus much more transmissible or infectious. The Delta variant is such an example. Initially we thought the SARS-CoV-2 reproductive rate was between 2.5 and 4. In other words, in a fully susceptible population every one person infected would on average infect about two and a half to four other people. But the Delta variant is at least twofold more transmissible. That means the reproductive rate of the Delta variant is probably closer to six rather than three.

The second change is that the virus has shown an ability to have mutations that make it resistant to antibody neutralising activity induced by past infection from the original virus, as well as antibody responses induced by most current Covid-19 vaccines.

Wits University's Prof Shabir Madhi. File photo.
Wits University's Prof Shabir Madhi. File photo.
Image: Supplied/Wits

The third big issue centres on the durability of protection. Our memory responses are lasting for at least six to nine months at the moment. But that doesn’t mean they will protect us against infection from variants that are evolving, even if such memory responses do assist in attenuating the clinical course of the infection leading to less severe Covid-19 illness.

The fourth issue conspiring against us being able to reach a herd immunity threshold any time soon is the inequitable distribution of vaccine across the world, the slow uptake and the sluggish rollout. Unfortunately, this provides fertile ground for ongoing evolution of the virus.

No country is going to lock its borders perpetually. This means the entire global population needs to reach the same sort of threshold at about the same time. To date only 1% of the populations of low-income countries have been vaccinated, and 27% of the global population.

With the Delta variant, we would need to get close to 84% of the global population developing protection against infection (in the absence of non-pharmacological interventions) in as brief a period of time as possible.

Next steps

The only sustainable solution is to learn to live with the virus.

This will require ensuring we get most individuals, especially adults, and particularly those at a higher risk of developing severe Covid-19 and dying, vaccinated as quickly as possible. In my view this could be achieved in SA with 20-million people vaccinated — not the 40-million target set by government. But the 20-million would need to include 90% of people above the age of 60, and 90% of people above the age of 35 who have comorbidities.

If SA achieved this milestone, it could get back to a relatively normal lifestyle even with the virus continuing to circulate and causing the occasional outbreak. It would also ensure a threshold that guaranteed its healthcare systems weren’t going to be overwhelmed, and that people were not going to die in large numbers.

We are simply going to have to become comfortable with the idea that SARS-CoV-2 is going to be like one of the many other viruses that circulate that cause respiratory illness each day. Usually mild infections, and less often a severe disease.

People will, unfortunately, continue dying of Covid-19, but certainly not at the magnitude that’s been seen over the past 18 months. A major advance would be for Covid-19 to be no more severe than what is seen every influenza season (10,000 to 11,000 deaths) in SA.

The UK experience is where we should be heading. That is getting back to a relatively normal lifestyle, provided we’ve got an adequate number of people vaccinated, and particularly people who are at higher risk of developing severe Covid-19.

In the UK, close to 85% of adults  have received at least a single dose of the vaccine. As a result they’re able to remove almost all restrictions.

The UK is seeing an increase in the number of cases of the Delta variant. But they’ve seen very nominal changes when it comes to hospitalisation and death. Most people (97%) who end up being hospitalised and dying of Covid-19 in the UK are those who decided not to be vaccinated.

  • Shabir A Madhi: dean faculty of health sciences and professor of vaccinology at University of the Witwatersrand; and director of the SA Medical Research Council vaccines and infectious diseases analytics research unit, University of the Witwatersrand

 


subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now